Does FEDRATINIB Cause Malignant neoplasm progression? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Malignant neoplasm progression have been filed in association with FEDRATINIB (Inrebic). This represents 0.5% of all adverse event reports for FEDRATINIB.
7
Reports of Malignant neoplasm progression with FEDRATINIB
0.5%
of all FEDRATINIB reports
1
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From FEDRATINIB?
Of the 7 reports, 1 (14.3%) resulted in death.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FEDRATINIB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does FEDRATINIB Cause?
Diarrhoea (143)
Death (138)
Nausea (114)
Fatigue (105)
Vomiting (74)
Constipation (59)
Platelet count decreased (48)
Asthenia (47)
Haemoglobin decreased (46)
Full blood count decreased (45)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which FEDRATINIB Alternatives Have Lower Malignant neoplasm progression Risk?
FEDRATINIB vs FELBAMATE
FEDRATINIB vs FELIS CATUS HAIR
FEDRATINIB vs FELODIPINE
FEDRATINIB vs FENFLURAMINE
FEDRATINIB vs FENOFIBRATE